DOJ and HHS open six-month window for healthcare companies to self-disclose False Claims Act violations

By ··1 min read·4 sources

A new pilot lets healthcare companies, including drug manufacturers, resolve previously unknown False Claims Act exposure by repaying 1.25 to 1.6 times the base amount. Participants avoid exclusion, corporate integrity agreements and civil monetary penalties.

The Department of Health and Human Services and the Justice Department's Civil Division announced the Healthcare False Claims Act Self-Disclosure Pilot Program on October 22, 2026. It runs for six months, and submissions are accepted only through April 22, 2027. Late or incomplete submissions will not be reviewed.

The pilot is open to healthcare companies, including manufacturers, that voluntarily disclose potential civil False Claims Act violations previously unknown to the government. Participants must disclose all relevant details, produce documents showing the nature and operation of the conduct, describe remediation and make a repayment calculated under the published protocol.

The repayment multiplier ranges from 1.25 to 1.6 times the base amount, depending on timeliness, the duration and scope of the conduct, senior leadership involvement, the financial benefit to the company and whether it inherited the conduct through an acquisition and promptly fixed it. That compares with the roughly 2.0 multiplier typical of negotiated FCA settlements and the 3.0 the statute allows. In return, DOJ grants a release, HHS-OIG will not impose exclusion or require a corporate integrity agreement, CMS will not revoke billing privileges, and neither agency will impose civil monetary penalties.

The pilot arrived alongside other DOJ moves to encourage reporting. On October 15, the National Fraud Enforcement Division and HHS-OIG made the division's Health Care Fraud Section the single entry point for criminal self-disclosures. On October 20 the division launched a Fraud Whistleblower Incentive Program for individuals.

For drug manufacturers, the timing is pointed. Dompé received credit for self-disclosing kickbacks in September, and Veloxis received cooperation credit in August. The pilot puts a published price on coming forward first, before a relator files.

Sources

  1. hhs.gov · hhs.gov/press-room/hhs-doj-launch-healthcare-false-claims-act-self-disclosure-pilot.html
  2. goodwinlaw.com · goodwinlaw.com/en/insights/publications/2026/10/alerts-practices-hltc-doj-hhs-announce-hea…
  3. troutman.com · troutman.com/insights/doj-civil-division-and-hhs-launch-healthcare-false-claims-act-self-d…
  4. mintz.com · mintz.com/insights-center/viewpoints/2406/2026-08-25-cooperation-compliance-and-consequenc…

Cite this report

The Precedent. "DOJ and HHS open six-month window for healthcare companies to self-disclose False Claims Act violations." October 24, 2026. https://theprecedent.org/article/doj-and-hhs-open-six-month-window-for-healthcare-companies-to-self-disclose-fals